Working hours:
Mon - Fri 9.00 - 18.00
After entering the query, click on the search result
Hong Kong time
Time in Hong Kong:
Home
About us
Company Profile/ Who we are?
Vision & Values
Business Segments
Geographic spread
Our Technology
Product Portfolio
Active pharmaceutical ingredients
Pharmaceutical intermediates
Pharmaceutical excipients
Policies
Privacy Statement
Ordering Details, Terms, and Conditions
Browser Recommendation
New Product Suggestion
Partner with us
Careers
Library
Contact
Working hours:
Mon - Fri 9.00 - 18.00
HOME
Library
ARTICLES
Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome
19.10.2021
/
ARTICLES
Effect of Oral Androstenedione on Serum Testosterone and Adaptations to Resistance Training in Young Men
10.10.2021
/
ARTICLES
The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men
03.10.2021
/
ARTICLES
Stanozolol promotes osteogenic gene expression and apposition of bone mineral in vitro
16.09.2021
/
ARTICLES
Effects of Acute Stanozolol Treatment on Puberty in Female Rats
21.09.2021
/
ARTICLES
Synthesis of some potent immunomodulatory and anti-inflammatory metabolites by fungal transformation of anabolic steroid oxymetholone
21.09.2021
/
ARTICLES
Use of altrenogest on pig farm
30.08.2021
/
ARTICLES
A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy
04.09.2021
/
ARTICLES
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
16.08.2021
/
ARTICLES
Safety and Efficacy of Oxandrolone in Growth Hormone-Treated Girls with Turner Syndrome: Evidence from Recent Studies and Recommendations for Use
03.08.2021
/
ARTICLES
Oxandrolone Enhances Hepatic Ketogenesis in Adult Men
28.07.2021
/
ARTICLES
Effect of Fluoxymesterone Fish Feed Granule on Sex Reversal of the Hybrid, Thai Red Tilapia (Oreochromis niloticus Linn. x Oreochromis mossambicus Linn.)
22.07.2021
/
Search
After entering the query, click on the search result
Ikigai Corporation Company is a leading pharmaceutical contract development and manufacturing organisation (CDMO) for both APIs and finished dose forms.
Home
About us
Our Technology
Product Portfolio
Policies
Partner with us
Careers
Library
Contact
Copyright © 2022 IKIGAI CORPORATION. All rights reserved.